|  Help  |  About  |  Contact Us

Publication : Acute gene inactivation in the adult mouse liver using the CRISPR-Cas9 technology.

First Author  Wang X Year  2021
Journal  STAR Protoc Volume  2
Issue  3 Pages  100611
PubMed ID  34189476 Mgi Jnum  J:382853
Mgi Id  MGI:6728378 Doi  10.1016/j.xpro.2021.100611
Citation  Wang X, et al. (2021) Acute gene inactivation in the adult mouse liver using the CRISPR-Cas9 technology. STAR Protoc 2(3):100611
abstractText  Genetic manipulation in mice allows the discovery of gene function and biological mechanisms in vivo. The widely used Cre/LoxP system usually takes months to years especially when starting with the production of floxed alleles of a new gene of interest (GOI). Here, we describe a protocol using the CRISPR-Cas9 system to acutely inactivate the GOI in adult mice. This protocol enables hepatocyte-specific gene editing within 4 weeks in adult mice and avoids compensatory effects of traditional gene inactivation initiated during various developmental stages. For complete details on the use and execution of this protocol, please refer to Wang et al. (2020).
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

3 Authors

5 Bio Entities

0 Expression